About Merit Medical Systems, Inc
Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, hemostasis, intervention, fluid management, electrophysiology and cardiac rhythm management, and hemodynamic monitoring to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, swab and collection systems, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, advanced over-the-wire and direct visualization delivery systems, and dilation balloons; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. The company was incorporated in 1987 and is headquartered in South Jordan, Utah. Address: 1600 West Merit Parkway, South Jordan, UT, United States, 84095
Merit Medical Systems, Inc News and around…
Latest news about Merit Medical Systems, Inc (MMSI) common stock and company :
Merit Medical Systems, Inc. ( NASDAQ:MMSI ) shareholders have seen the share price descend 14% over the month. But at...
Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...
Investors in Merit Medical Systems, Inc. (MMSI) saw new options become available this week, for the June 17th expiration..
Merit Medical (MMSI), in the first quarter, benefits from revenue growth in both its segments and from all of the product categories within its Cardiovascular unit.
Merit Medical (MMSI) delivered earnings and revenue surprises of 12.77% and 4.54%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Q1 2022 reported revenue of $275.4 million, up 10.6% compared to Q1 2021Q1 2022 constant currency revenue, organic* up 11.3% compared to Q1 2021Q1 2022 GAAP EPS $0.18, compared to $0.19 in Q1 2021Q1 2022 non-GAAP EPS* of $0.53, compared to $0.52 in Q1 2021 * Constant currency revenue; constant currency revenue, organic; non-GAAP EPS; non-GAAP net income; non-GAAP operating income and margin; non-GAAP gross margin; and free cash flow are non-GAAP financial measures. A reconciliation of these fina
Ronald A. Frost to Retire After More than 30 Years of ServiceNeil Peterson, a 27-Year Company Veteran, Appointed COO SOUTH JORDAN, Utah, April 21, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that Chief Operating Officer (COO) Ronald A. Frost has decided to retire for personal reasons. Neil Peterson, Vice President, Operations, has been appointed as COO, effective immediately. During his
SOUTH JORDAN, Utah, April 21, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, is proud to announce that Brian G. Lloyd, Merit’s Chief Legal Officer and Corporate Secretary, is a recipient of Utah Business Magazine’s Corporate Counsel Award. The award recognizes exceptional in-house counselors who serve the state’s businesses, nonprofit organizations, and other private-sector organizations. This year’s award
Merit Medical (MMSI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Merit Medical Systems, Inc. (MMSI) was identified as having a larger market cap than the smaller end of the S&P 500, for example Under Armour Inc (UA), according to The Online Investor..
Merit Medical's (MMSI) latest well-designed tray is expected to simplify the thoracostomy procedure and reduce treatment time, especially in critical situations.
At the Annual Needham Healthcare Conference,Merit Medical Systems Inc's(NASDAQ: MMSI) management said that ...
Intuitive design facilitates procedural efficiency, supports minimally invasive patient careSOUTH JORDAN, Utah, April 18, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced the launch of the ReSolve® Thoracostomy Tray. The new tray contains all products needed for performing a thoracostomy, a minimally invasive technique that allows patients to avoid an open surgical procedure to drain fluids o
There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'll want to see a...
SOUTH JORDAN, Utah, April 13, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will release its financial results for the quarter ended March 31, 2022, after the close of the stock market on Wednesday, April 27, 2022. Merit will hold its investo
Merit Medical's (MMSI) receipt of FDA clearance for the SCOUT Bx system can streamline treatment for cancer patients.
New technology is designed to allow physicians to place SCOUT® reflector at time of biopsy for breast localization under stereotactic and MRI guidanceSOUTH JORDAN, Utah, April 11, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, has received FDA clearance for the SCOUT Bx™ Delivery System, the first wire-free breast localization solution that can be deployed at the time of stereotactic or MRI-guided biopsy.
Investors continue to be optimistic about Merit Medical (MMSI) owing to its strong product portfolio.
Merger activity declined last week with three new deals announced and five deals completed. Two of the three new deals announced were ...
Merit Medical Systems Inc(NASDAQ: MMSI) is exploring options that include an outright sale to a private equity ...
Merit Medical Systems (NASDAQ:MMSI) has had a great run on the share market with its stock up by a significant 11% over...
Receipt of the Breakthrough Device Designation for Merit Medical's (MMSI) Embosphere Microspheres is expected to improve patient outcome.
SOUTH JORDAN, Utah, March 07, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), announced today that it has received “breakthrough device designation” from the U.S. Food & Drug Administration (FDA) for Embosphere® Microspheres for the Genicular Artery Embolization (GAE) indication. GAE is a procedure intended to reduce pain and disability caused by knee osteoarthritis by reducing blood flow to the knee, minimizing the inflammatory process. As a market-leading solution in embol
Merit Medical (MMSI), in the fourth quarter, benefits from revenue growth in both its segments, and from majority of the product categories within its Cardiovascular unit.
Merit Medical (MMSI) delivered earnings and revenue surprises of 42% and 3.17%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Merit Medical Systems (NASDAQ:MMSI) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:05 PM. Here's what ...
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David ...
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and ...
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Oxford Industries, Inc. (OXM), where a total volume of 407 contracts has been traded thus far today, a contract volume which is representative of approximately 40,700 underlying shares (given that every 1 contract represents 100 underlying shares)..
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares Evolved US.
Merit Medical Systems, Inc (MMSI) is a NASDAQ Common Stock listed in Common Stock, Healthcare, Medical Instruments & Supplies
